Sfoglia per AUTORE
SHAH R
Collezione ASL Alessandria

  

Items : 1

NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trial. in The Lancet. Oncology / Lancet Oncol. 2018 Jun;19(6):799-811. doi: 10.1016/S1470-2045(18)30193-1. Epub 2018 May 9.

2018
AOU San Luigi di Orbassano
ASL Alessandria

Bearz A; Muzio A; Novello S; Taylor P; Shah R; Tiseo M; Bidoli P; Polychronis A; Jassem J; Grossi F; Favaretto A; Gaafar RM; Gregorc V; Lambiase A; O'Brien M; Greillier L; Fontana F; Salini G;